InvestorsHub Logo
Followers 19
Posts 1549
Boards Moderated 0
Alias Born 10/18/2010

Re: OTC BB King post# 9862

Saturday, 10/23/2010 11:13:15 AM

Saturday, October 23, 2010 11:13:15 AM

Post# of 129051
I wish I knew more about the legal subtleties here, but the way they talk about the CBIS-SFIO JV makes it sound like it is a project apart from CBIS' own internal projects dependent upon US FDA approval. Here are some excerpts from SFIO's release that get my attention:

confirmed today the announcement by the Biotech company Cannabis Science (OTCBB:CBIS) regarding entering into a joint venture agreement to develop and market several high-tech smoke-free vaporized medical cannabis pharmaceutical products, as released by CBIS on August 13. He stated, “Pursuant to the joint venture, Smokefree Innotec Inc will supply its high-tech smoke-free vapor technology devices and Cannabis Science will provide all the medical cannabis extract formulations.”
George Roth, CFO stated, “Our business of designing, developing, manufacturing and marketing hi-tech, nicotine and non-nicotine cigarette-like delivery devices which are completely smoke and vapor-free and tobacco-free, represents an excellent partnering with Cannabis Science to fill their needs for production and distribution in the fourteen US States that currently approve the medical use of cannabis.


Mr. Roth added, “It is worth repeating that this partnering with Cannabis Science will put Smokefree Innotec in the forefront of marketing devices delivering medical formulations of pharmacological extracts to dispensaries and healing centers already in existence, in compliance with applicable federal and state regulations. With the anticipated voter approval of Prop 19 in California, we believe the number of dispensaries and related retail establishments for marijuana and marijuana accessories will multiply rapidly.


In an earlier release, Dr. Robert Melamede, President and CEO of Cannabis Science Inc., stated, “Many patients smoke medical cannabis because it gives them rapid relief that allows them to monitor their usage. Smokefree Innotec’s technology allows the patients even greater convenience and dosage control than smoking, without all of the possible health and social/legal problems associated with smoking. Cannabis Science will provide a variety of standardized medical marijuana formulations to be used with the Smokefree Innotec products, so that patients can self-monitor their dosages. Of course, these products will be of even greater value to patients who do not like to smoke since vaporizing minimizes the irritating and harmful effects caused by direct smoke contacting the lungs.”



What I glean from this is that CBIS could serve SFIO has a sort of scientific adviser to develop their cannabis smokefree device targeted to existing MMJ patients.

I'm not as familiar with SFIO, do we have any word from them about timelines for deployment of a cannabis device within or without the US?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.